BioSpace News Archive

Business

Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3

Bausch Health Companies Inc. will release its second-quarter 2021 financial results on Tuesday, Aug. 3, 2021.

July 6, 2021
·
1 min read
Drug Development

Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML

Marker Therapeutics, Inc. announced completion of the six-patient safety lead-in portion of the Company’s Phase 2 trial of MT-401, its lead MultiTAA-specific T cell product candidate, for the treatment of post-transplant acute myeloid leukemia.

July 6, 2021
·
4 min read
Genetown

Allurion Technologies Unveils Transformed Allurion™ Weight Loss Program and New Corporate Brand

Allurion Technologies announced today two major milestones with the launch of the transformed Allurion Weight Loss Program and new worldwide brand for the company and its program.

July 6, 2021
·
3 min read
Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab)

Alvotech today announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04.

July 6, 2021
·
5 min read
Business

Amolyt Pharma Announces Hiring of Louis J. Arcudi III as Chief Financial Officer

Amolyt Pharma, a global company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has hired biotechnology senior executive Louis J. Arcudi III as chief financial officer.

July 6, 2021
·
3 min read
Rosinbomb™ Announces Exclusive Product Collaboration With ArdentIndustry Leaders Team Up to Create First Ever Extraction Press/ Infuser Combination in Time for 710!

ROSINBOMB (OTC:ROSN) and ARDENT industry leading developers and manufacturers of highly acclaimed groundbreaking solventless extraction and infusion technology products announced today the launch of two exclusive limited edition solution bundles in time for 710.

July 6, 2021
·
4 min read
Business

Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer.

July 6, 2021
·
9 min read
Medical Automation Market Segmentation & Future opportunities 2024

In a highly competitive pharmaceutical industry, automation can prove to be a massive operational advantage and a key differentiator for players of all sizes.

July 6, 2021
·
5 min read
Handheld Drug Detector Market – A Study on Portable Devices Used For Drug Detection

Illicit consumption and distribution of controlled substances such as narcotics are noteworthy public safety issues in numerous countries worldwide.

July 6, 2021
·
3 min read
Medical Device CROs Market: Advent of digital transformation and IoT-enabled sensors in healthcare has generated humongous revenues within the market

The global demand for medical device CRO is slated to rise at a sturdy pace in the times of follow. The presence of a seamless industry for managing medical technologies and fresh developments in healthcare has emerged as an important dynamic of market growth.

July 6, 2021
·
4 min read